Roche and Galapagos in COPD Alliance
By Taskin Ahmed
Pharma Deals Review: Vol 2010 Issue 1 (Table of Contents)
Published: 22 Jan-2010
DOI: 10.3833/pdr.v2010.i1.1304 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In an aim to bolster its pipeline with early research candidates, Roche signed a deal worth over US$580 M with Galapagos to develop new therapies in chronic obstructive pulmonary disease (COPD) using the latter’s proprietary discovery platforms...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS